The story of Sildenafil presents a nuanced case for stakeholders in the drug sector. While initially a tremendous success, generating billions, the intellectual property expiration and the subsequent flood of cheaper https://pharma894170.slypage.com/42327624/viagra-and-big-pharma-a-risky-bet